Brolucizumab: the road ahead

• Published in: British journal of ophthalmology Vol. 104; no. 12; pp. 1631 - 1632
• Main Authors: Sharma, Ashish, Kumar, Nilesh, Bandello, Francesco, Kuppermann, Baruch D, Loewenstein, Anat, Regillo, Carl D
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 01.12.2020
• Subjects: Antibodies, Monoclonal, Humanized - administration & dosage; Biological products; Drug dosages; FDA approval; Female; Humans; Inflammation; Intravitreal Injections; Macular degeneration; Male; Monoclonal antibodies; Retinal Diseases - drug therapy; Vascular endothelial growth factor; United States > US; India; Drugs; Retina; Immunology

Correspondence to Ashish Sharma, Lotus Eye Hospital and Institute, Avinashi Road, Civil Aerodrome Post, Peelamedu, Coimbatore, Tamil Nadu 641014, India; drashish79@hotmail.com The management and outcome of retinal disorders was revolutionised with the advent of ocular anti-vascular endothelial growt...